Catalyst Wire Dossier Catalyst Wire Dossier

ASF-1096 Cream 0.5%

· Astion Pharma A/S
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ASF-1096 Cream 0.5%, covering 2008-02-29 to 2008-02-29. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions (2) [Phase 2]

See pricing